Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - Category: Cancer & Oncology Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Neurology | Vaccines